Change language
English Deutsch
Change currency
€ EUR £ GBP $ USD
Licensed Unlicensed Requires Authentication Published by De Gruyter January 3, 2018

Acknowledgment

From the journal Drug Metabolism and Personalized Therapy
https://doi.org/10.1515/dmpt-2017-2000
Published Online: 2018-1-3
Published in Print: 2017-12-20

©2018 Walter de Gruyter GmbH, Berlin/Boston

From the journal
Drug Metabolism and Personalized Therapy
Drug Metabolism and Personalized Therapy
Volume 32 Issue 4
Submit manuscript

Journal and Issue

Articles in the same Issue

Frontmatter
Editorial
Creation of the Swiss group of Pharmacogenomics and personalised Therapy (SPT)
Publisher’s Note
Swarup A.V. Shah won the poster award at the 4th Annual Conference of ESPT
Original Articles
COQ2 polymorphisms are not associated with increased risk of statin-induced myalgia/myopathy in the Czech population
Role of CYP4F2, CYP2C19, and CYP1A2 polymorphisms on acenocoumarol pharmacogenomic algorithm accuracy improvement in the Greek population: need for sub-phenotype analysis
Estimation of fractions metabolized by hepatic CYP enzymes using a concept of inter-system extrapolation factors (ISEFs) – a comparison with the chemical inhibition method
In vitro modulation of the cytochrome P450 and ABCB1/P-glycoprotein activities of the aqueous extract of Allophylus cominia (L) Sw. leaves
Thymidylate synthase gene variants as predictors of clinical response and toxicity to fluoropyrimidine-based chemotherapy for colorectal cancer
Drug-drug interactions in cancer chemotherapy: an observational study in a tertiary health care centre
Acknowledgment
Downloaded on 23.3.2023 from https://www.degruyter.com/document/doi/10.1515/dmpt-2017-2000/html
Scroll Up Arrow